Search
Close this search box.
Search
[custom_company_search_form]
Lithium
46.07
1.86%
Gold
2,645.80
(0.38%)
Copper
4.52
0.4%
Oil
74.38
0.58%
Bitcoin
62,009.48
(0.09%)
FTSE 100
8,280.60
(0.02%)
Nikkei 225
38,635.62
0.11%
Dow Jones
42,352.75
0.25%
Iron Ore
108.70
(0.29%)
USD/AUD
0.69
0%
Hang Seng
22,736.87
3.28%
Lithium
46.07
1.86%
Gold
2,645.80
(0.38%)
Copper
4.52
0.4%
Oil
74.38
0.58%
Bitcoin
62,009.48
(0.09%)
FTSE 100
8,280.60
(0.02%)
Nikkei 225
38,635.62
0.11%
Dow Jones
42,352.75
0.25%
Iron Ore
108.70
(0.29%)
USD/AUD
0.69
0%
Hang Seng
22,736.87
3.28%
Lithium
46.07
1.86%
Gold
2,645.80
(0.38%)
Copper
4.52
0.4%
Oil
74.38
0.58%
Bitcoin
62,009.48
(0.09%)
FTSE 100
8,280.60
(0.02%)
Nikkei 225
38,635.62
0.11%
Dow Jones
42,352.75
0.25%
Iron Ore
108.70
(0.29%)
USD/AUD
0.69
0%
Hang Seng
22,736.87
3.28%
Lithium
46.07
1.86%
Gold
2,645.80
(0.38%)
Copper
4.52
0.4%
Oil
74.38
0.58%
Bitcoin
62,009.48
(0.09%)
FTSE 100
8,280.60
(0.02%)
Nikkei 225
38,635.62
0.11%
Dow Jones
42,352.75
0.25%
Iron Ore
108.70
(0.29%)
USD/AUD
0.69
0%
Hang Seng
22,736.87
3.28%
Lithium
46.07
1.86%
Gold
2,645.80
(0.38%)
Copper
4.52
0.4%
Oil
74.38
0.58%
Bitcoin
62,009.48
(0.09%)
FTSE 100
8,280.60
(0.02%)
Nikkei 225
38,635.62
0.11%
Dow Jones
42,352.75
0.25%
Iron Ore
108.70
(0.29%)
USD/AUD
0.69
0%
Hang Seng
22,736.87
3.28%
Lithium
46.07
1.86%
Gold
2,645.80
(0.38%)
Copper
4.52
0.4%
Oil
74.38
0.58%
Bitcoin
62,009.48
(0.09%)
FTSE 100
8,280.60
(0.02%)
Nikkei 225
38,635.62
0.11%
Dow Jones
42,352.75
0.25%
Iron Ore
108.70
(0.29%)
USD/AUD
0.69
0%
Hang Seng
22,736.87
3.28%
Lithium
46.07
1.86%
Gold
2,645.80
(0.38%)
Copper
4.52
0.4%
Oil
74.38
0.58%
Bitcoin
62,009.48
(0.09%)
FTSE 100
8,280.60
(0.02%)
Nikkei 225
38,635.62
0.11%
Dow Jones
42,352.75
0.25%
Iron Ore
108.70
(0.29%)
USD/AUD
0.69
0%
Hang Seng
22,736.87
3.28%
Lithium
46.07
1.86%
Gold
2,645.80
(0.38%)
Copper
4.52
0.4%
Oil
74.38
0.58%
Bitcoin
62,009.48
(0.09%)
FTSE 100
8,280.60
(0.02%)
Nikkei 225
38,635.62
0.11%
Dow Jones
42,352.75
0.25%
Iron Ore
108.70
(0.29%)
USD/AUD
0.69
0%
Hang Seng
22,736.87
3.28%
Lithium
46.07
1.86%
Gold
2,645.80
(0.38%)
Copper
4.52
0.4%
Oil
74.38
0.58%
Bitcoin
62,009.48
(0.09%)
FTSE 100
8,280.60
(0.02%)
Nikkei 225
38,635.62
0.11%
Dow Jones
42,352.75
0.25%
Iron Ore
108.70
(0.29%)
USD/AUD
0.69
0%
Hang Seng
22,736.87
3.28%
Lithium
46.07
1.86%
Gold
2,645.80
(0.38%)
Copper
4.52
0.4%
Oil
74.38
0.58%
Bitcoin
62,009.48
(0.09%)
FTSE 100
8,280.60
(0.02%)
Nikkei 225
38,635.62
0.11%
Dow Jones
42,352.75
0.25%
Iron Ore
108.70
(0.29%)
USD/AUD
0.69
0%
Hang Seng
22,736.87
3.28%

Stock Piper AI Index

Stock Piper AI Index

Subscribe
Lithium
46.07
1.86%
Gold
2,645.80
(0.38%)
Copper
4.52
0.4%
Oil
74.38
0.58%
Bitcoin
62,009.48
(0.09%)
FTSE 100
8,280.60
(0.02%)
Nikkei 225
38,635.62
0.11%
Dow Jones
42,352.75
0.25%
Iron Ore
108.70
(0.29%)
USD/AUD
0.69
0%
Hang Seng
22,736.87
3.28%
Lithium
46.07
1.86%
Gold
2,645.80
(0.38%)
Copper
4.52
0.4%
Oil
74.38
0.58%
Bitcoin
62,009.48
(0.09%)
FTSE 100
8,280.60
(0.02%)
Nikkei 225
38,635.62
0.11%
Dow Jones
42,352.75
0.25%
Iron Ore
108.70
(0.29%)
USD/AUD
0.69
0%
Hang Seng
22,736.87
3.28%
Lithium
46.07
1.86%
Gold
2,645.80
(0.38%)
Copper
4.52
0.4%
Oil
74.38
0.58%
Bitcoin
62,009.48
(0.09%)
FTSE 100
8,280.60
(0.02%)
Nikkei 225
38,635.62
0.11%
Dow Jones
42,352.75
0.25%
Iron Ore
108.70
(0.29%)
USD/AUD
0.69
0%
Hang Seng
22,736.87
3.28%
Lithium
46.07
1.86%
Gold
2,645.80
(0.38%)
Copper
4.52
0.4%
Oil
74.38
0.58%
Bitcoin
62,009.48
(0.09%)
FTSE 100
8,280.60
(0.02%)
Nikkei 225
38,635.62
0.11%
Dow Jones
42,352.75
0.25%
Iron Ore
108.70
(0.29%)
USD/AUD
0.69
0%
Hang Seng
22,736.87
3.28%
Lithium
46.07
1.86%
Gold
2,645.80
(0.38%)
Copper
4.52
0.4%
Oil
74.38
0.58%
Bitcoin
62,009.48
(0.09%)
FTSE 100
8,280.60
(0.02%)
Nikkei 225
38,635.62
0.11%
Dow Jones
42,352.75
0.25%
Iron Ore
108.70
(0.29%)
USD/AUD
0.69
0%
Hang Seng
22,736.87
3.28%
Lithium
46.07
1.86%
Gold
2,645.80
(0.38%)
Copper
4.52
0.4%
Oil
74.38
0.58%
Bitcoin
62,009.48
(0.09%)
FTSE 100
8,280.60
(0.02%)
Nikkei 225
38,635.62
0.11%
Dow Jones
42,352.75
0.25%
Iron Ore
108.70
(0.29%)
USD/AUD
0.69
0%
Hang Seng
22,736.87
3.28%
Lithium
46.07
1.86%
Gold
2,645.80
(0.38%)
Copper
4.52
0.4%
Oil
74.38
0.58%
Bitcoin
62,009.48
(0.09%)
FTSE 100
8,280.60
(0.02%)
Nikkei 225
38,635.62
0.11%
Dow Jones
42,352.75
0.25%
Iron Ore
108.70
(0.29%)
USD/AUD
0.69
0%
Hang Seng
22,736.87
3.28%
Lithium
46.07
1.86%
Gold
2,645.80
(0.38%)
Copper
4.52
0.4%
Oil
74.38
0.58%
Bitcoin
62,009.48
(0.09%)
FTSE 100
8,280.60
(0.02%)
Nikkei 225
38,635.62
0.11%
Dow Jones
42,352.75
0.25%
Iron Ore
108.70
(0.29%)
USD/AUD
0.69
0%
Hang Seng
22,736.87
3.28%
Lithium
46.07
1.86%
Gold
2,645.80
(0.38%)
Copper
4.52
0.4%
Oil
74.38
0.58%
Bitcoin
62,009.48
(0.09%)
FTSE 100
8,280.60
(0.02%)
Nikkei 225
38,635.62
0.11%
Dow Jones
42,352.75
0.25%
Iron Ore
108.70
(0.29%)
USD/AUD
0.69
0%
Hang Seng
22,736.87
3.28%
Lithium
46.07
1.86%
Gold
2,645.80
(0.38%)
Copper
4.52
0.4%
Oil
74.38
0.58%
Bitcoin
62,009.48
(0.09%)
FTSE 100
8,280.60
(0.02%)
Nikkei 225
38,635.62
0.11%
Dow Jones
42,352.75
0.25%
Iron Ore
108.70
(0.29%)
USD/AUD
0.69
0%
Hang Seng
22,736.87
3.28%

Race Oncology Ltd

RAC

ASX

Race Oncology (RAC), an Australian-based clinical-stage biopharmaceutical company, is driven by a dedicated mission to be at the forefront of advancements in cancer care. They focus on developing innovative therapies that target not only the eradication of cancer but also the well-being of patients throughout treatment.

Latest Posts

Line Chart with Gradient
Price
$1.69
0 (0%)
At Close 04/10 (AEST)
Related Companies
DIMERIX LIMITED
$DXB
AUSCANN GROUP HOLDINGS LTD
$AC8
MAYNE PHARMA GROUP LIMITED
$MYX
CLEO DIAGNOSTICS LTD
$COV
PYC THERAPEUTICS LIMITED
$PYC

Latest Posts

race-oncology-asx-rac-announces-board-renewal-completion-rac
Health Care $RAC

Race Oncology (ASX: $RAC) announces board renewal completion

Dr Pete Smith appointed as Executive Chair, Dr Daniel Tillett as Managing Director & CEO, and Dr Serge Scrofani joins as Independent Non-Executive Director

September 2, 2024
race-oncology-asx-rac-appoints-george-clinical-to-support-phase-1a-1b-trial-rac
Health Care $RAC

Race Oncology (ASX: $RAC) appoints george clinical to support phase 1a/1b trial

George Clinical International appointed to support clinical development of RC220 bisantrene in solid tumour patients

June 20, 2024
race-oncology-asx-rac-secures-us-fda-rare-paediatric-disease-designation-for-rc220-bisantrene-rac
Health Care $RAC

Race Oncology (ASX: $RAC) secures US FDA rare paediatric disease designation for RC220 bisantrene

US FDA designation enables potential for lucrative Priority Review Voucher

June 18, 2024
race-oncology-asx-rac-completes-cgmp-manufacturing-for-bisantrene-formulation-rc220-rac
Health Care $RAC

Race Oncology (ASX: $RAC) completes cGMP manufacturing for bisantrene formulation RC220

Certificate of Analysis confirms RC220 meets cGMP specifications for human IV drug product

March 26, 2024
race-oncology-asx-rac-presents-potent-anticancer-activity-in-aml-models-rac
Health Care $RAC

Race Oncology (ASX: $RAC) presents potent anticancer activity in AML models

Bisantrene exhibits robust anticancer synergy in AML models

March 6, 2024
race-oncology-asx-rac-receives-4-0m-rd-tax-refund-rac
Health Care $RAC

Race Oncology (ASX: $RAC) receives $4.0m r&d tax refund

Australian biopharmaceutical company to utilize funds for clinical development of bisantrene in 2024

February 27, 2024

RAC

$RAC

Race Oncology (ASX: $RAC) announces board renewal completion

Dr Pete Smith appointed as Executive Chair, Dr Daniel Tillett as Managing Director & CEO, and Dr Serge Scrofani joins as Independent Non-Executive Director

RAC

$RAC

Race Oncology (ASX: $RAC) appoints george clinical to support phase 1a/1b trial

George Clinical International appointed to support clinical development of RC220 bisantrene in solid tumour patients

RAC

$RAC

Race Oncology (ASX: $RAC) secures US FDA rare paediatric disease designation for RC220 bisantrene

US FDA designation enables potential for lucrative Priority Review Voucher

RAC

$RAC

Race Oncology (ASX: $RAC) completes cGMP manufacturing for bisantrene formulation RC220

Certificate of Analysis confirms RC220 meets cGMP specifications for human IV drug product

RAC

$RAC

Race Oncology (ASX: $RAC) presents potent anticancer activity in AML models

Bisantrene exhibits robust anticancer synergy in AML models

RAC

$RAC

Race Oncology (ASX: $RAC) receives $4.0m r&d tax refund

Australian biopharmaceutical company to utilize funds for clinical development of bisantrene in 2024

Related Companies
ANAGENICS LIMITED
$AN1
RECCE PHARMACEUTICALS LTD
$RCE
PROBIOTEC LIMITED
$PBP
CLARITY PHARMACEUTICALS LTD
$CU6
LTR PHARMA LIMITED
$LTP

ASX News, First
& Fast.

By clicking Subscribe, you agree to our Terms & Conditions

ASX News, First And Fast.

By clicking Subscribe, you agree to our Terms & Conditions

© 2024 Stock Piper. All rights reserved

© 2024 Stock Piper.
All rights reserved

Blog

Healthcare
Materials
Real Estate
Consumer Staples
Consumer Discretionary Brief
Utilities

Company

About us
Terms of use
Privacy Policy

Support

Request Form
Contact Support
FAQ
Glossary

Socials

Facebook
Twitter
LinkedIn
© 2024 Stock Piper. All rights reserved
Social Media Auto Publish Powered By : XYZScripts.com
Join FREE Newsletter

Stock Piper AI Index Coming Soon!

Join our Newsletter to gain exclusive insight and be notified once we are live.

By clicking Subscribe, you agree to our Terms & Conditions

ASX News, First And Fast.

Get all the latest market updates straight to your inbox.

By clicking Subscribe, you agree to our Terms & Conditions